Tony Michael Argenbright
Examiner (ID: 16324)
Most Active Art Unit | 3402 |
Art Unit(s) | 3402, 3747 |
Total Applications | 2731 |
Issued Applications | 2589 |
Pending Applications | 40 |
Abandoned Applications | 102 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 6134874
[patent_doc_number] => 20110008762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Methods for Preserving Organs and Tissues'
[patent_app_type] => utility
[patent_app_number] => 12/727637
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11432
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008762.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727637
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727637 | Methods for preserving organs and tissues | Mar 18, 2010 | Issued |
Array
(
[id] => 6639592
[patent_doc_number] => 20100174048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'Processes for Preparing a Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 12/727758
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11997
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0174/20100174048.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727758
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727758 | Processes for Preparing a Polypeptide | Mar 18, 2010 | Abandoned |
Array
(
[id] => 6571294
[patent_doc_number] => 20100234566
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Processes for Preparing a Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 12/727653
[patent_app_country] => US
[patent_app_date] => 2010-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12166
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234566.pdf
[firstpage_image] =>[orig_patent_app_number] => 12727653
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/727653 | Processes for Preparing a Polypeptide | Mar 18, 2010 | Abandoned |
Array
(
[id] => 6566446
[patent_doc_number] => 20100234272
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'Processes for Preparing a Polypeptide'
[patent_app_type] => utility
[patent_app_number] => 12/726571
[patent_app_country] => US
[patent_app_date] => 2010-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12163
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234272.pdf
[firstpage_image] =>[orig_patent_app_number] => 12726571
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/726571 | Processes for preparing a polypeptide | Mar 17, 2010 | Issued |
Array
(
[id] => 7744225
[patent_doc_number] => 20120021969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'PROSTHETIC IMPLANT SHELL'
[patent_app_type] => utility
[patent_app_number] => 13/254393
[patent_app_country] => US
[patent_app_date] => 2010-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4039
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021969.pdf
[firstpage_image] =>[orig_patent_app_number] => 13254393
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/254393 | PROSTHETIC IMPLANT SHELL | Mar 2, 2010 | Abandoned |
Array
(
[id] => 7651805
[patent_doc_number] => 20110301074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-08
[patent_title] => 'PROTEIN PREPARATION PRODUCED FROM RAPE SEEDS'
[patent_app_type] => utility
[patent_app_number] => 13/201480
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8855
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0301/20110301074.pdf
[firstpage_image] =>[orig_patent_app_number] => 13201480
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/201480 | Protein preparation produced from rape seeds | Feb 25, 2010 | Issued |
Array
(
[id] => 6532400
[patent_doc_number] => 20100221341
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'Alanine-Based Peptide Hydrogels'
[patent_app_type] => utility
[patent_app_number] => 12/713820
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 7361
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221341.pdf
[firstpage_image] =>[orig_patent_app_number] => 12713820
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/713820 | Alanine-Based Peptide Hydrogels | Feb 25, 2010 | Abandoned |
Array
(
[id] => 10121433
[patent_doc_number] => 09155780
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-13
[patent_title] => 'Short beta-defensin-derived peptides'
[patent_app_type] => utility
[patent_app_number] => 13/148376
[patent_app_country] => US
[patent_app_date] => 2010-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 22
[patent_no_of_words] => 18461
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13148376
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/148376 | Short beta-defensin-derived peptides | Feb 9, 2010 | Issued |
Array
(
[id] => 6137742
[patent_doc_number] => 20110009669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'ABUSE-RESISTANT AMPHETAMINE PRODRUGS'
[patent_app_type] => utility
[patent_app_number] => 12/701483
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 92
[patent_figures_cnt] => 92
[patent_no_of_words] => 42263
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20110009669.pdf
[firstpage_image] =>[orig_patent_app_number] => 12701483
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/701483 | ABUSE-RESISTANT AMPHETAMINE PRODRUGS | Feb 4, 2010 | Abandoned |
Array
(
[id] => 7791666
[patent_doc_number] => 20120053222
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-01
[patent_title] => 'Novel Metabolic Disease Therapy'
[patent_app_type] => utility
[patent_app_number] => 13/145906
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 14444
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0053/20120053222.pdf
[firstpage_image] =>[orig_patent_app_number] => 13145906
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/145906 | Novel Metabolic Disease Therapy | Jan 21, 2010 | Abandoned |
Array
(
[id] => 7685442
[patent_doc_number] => 20100120699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'METHOD FOR SYNTHESIZING KPV TRIPEPTIDE DIAMIDE DERIVATES'
[patent_app_type] => utility
[patent_app_number] => 12/692141
[patent_app_country] => US
[patent_app_date] => 2010-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9821
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120699.pdf
[firstpage_image] =>[orig_patent_app_number] => 12692141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/692141 | METHOD FOR SYNTHESIZING KPV TRIPEPTIDE DIAMIDE DERIVATES | Jan 21, 2010 | Abandoned |
Array
(
[id] => 7587285
[patent_doc_number] => 20110281795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-11-17
[patent_title] => 'GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/146220
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20700
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20110281795.pdf
[firstpage_image] =>[orig_patent_app_number] => 13146220
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/146220 | GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE | Jan 14, 2010 | Abandoned |
Array
(
[id] => 7685451
[patent_doc_number] => 20100120690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same'
[patent_app_type] => utility
[patent_app_number] => 12/687267
[patent_app_country] => US
[patent_app_date] => 2010-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25241
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120690.pdf
[firstpage_image] =>[orig_patent_app_number] => 12687267
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/687267 | Polypeptides Having Antimicrobial Activity and Polynucleotides Encoding Same | Jan 13, 2010 | Abandoned |
Array
(
[id] => 4624302
[patent_doc_number] => 08003598
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Peptide anti-tumor agent'
[patent_app_type] => utility
[patent_app_number] => 12/647899
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 8648
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003598.pdf
[firstpage_image] =>[orig_patent_app_number] => 12647899
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/647899 | Peptide anti-tumor agent | Dec 27, 2009 | Issued |
Array
(
[id] => 7663629
[patent_doc_number] => 20110312898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER'
[patent_app_type] => utility
[patent_app_number] => 13/142414
[patent_app_country] => US
[patent_app_date] => 2009-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 58985
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20110312898.pdf
[firstpage_image] =>[orig_patent_app_number] => 13142414
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/142414 | PROPHYLACTIC / THERAPEUTIC AGENT FOR CANCER | Dec 27, 2009 | Abandoned |
Array
(
[id] => 7490058
[patent_doc_number] => 20110237493
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'DIPEPTIDE LINKED MEDICINAL AGENTS'
[patent_app_type] => utility
[patent_app_number] => 13/130963
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28474
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0237/20110237493.pdf
[firstpage_image] =>[orig_patent_app_number] => 13130963
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/130963 | DIPEPTIDE LINKED MEDICINAL AGENTS | Dec 17, 2009 | Abandoned |
Array
(
[id] => 6295260
[patent_doc_number] => 20100160230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-24
[patent_title] => 'UBIQUITIN AND UBIQUITIN RELATED MOLECULES FOR TREATMENT AND PREVENTION OF HARMFUL ACTIVATION OF THE IMMUNE SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 12/642219
[patent_app_country] => US
[patent_app_date] => 2009-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 12033
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20100160230.pdf
[firstpage_image] =>[orig_patent_app_number] => 12642219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/642219 | UBIQUITIN AND UBIQUITIN RELATED MOLECULES FOR TREATMENT AND PREVENTION OF HARMFUL ACTIVATION OF THE IMMUNE SYSTEM | Dec 17, 2009 | Abandoned |
Array
(
[id] => 6492333
[patent_doc_number] => 20100093605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-15
[patent_title] => 'PEPTIDES, DERIVATIVES AND ANALOGS THEREOF, AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/635053
[patent_app_country] => US
[patent_app_date] => 2009-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 26613
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20100093605.pdf
[firstpage_image] =>[orig_patent_app_number] => 12635053
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/635053 | Peptides, derivatives and analogs thereof, and methods of using same | Dec 9, 2009 | Issued |
Array
(
[id] => 6499201
[patent_doc_number] => 20100215583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-26
[patent_title] => 'CELL NUCLEUS-ENTERING COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 12/632654
[patent_app_country] => US
[patent_app_date] => 2009-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10204
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20100215583.pdf
[firstpage_image] =>[orig_patent_app_number] => 12632654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/632654 | CELL NUCLEUS-ENTERING COMPOSITIONS | Dec 6, 2009 | Abandoned |
Array
(
[id] => 6453768
[patent_doc_number] => 20100105606
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'METHODS FOR MAKING HIGH OXYGEN AFFINITY MODIFIED HEMOGLOBIN FOR OXYGEN TRANSPORT'
[patent_app_type] => utility
[patent_app_number] => 12/625900
[patent_app_country] => US
[patent_app_date] => 2009-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 12503
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105606.pdf
[firstpage_image] =>[orig_patent_app_number] => 12625900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/625900 | Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin | Nov 24, 2009 | Issued |